Future Directions in Medication Treatments for ASD

• By: Evdokia Anagnostou, MD Bloorview Research Institute at University of Toronto Joel D. Bregman, MD Thompson Center for Autism and Neurodevelopmental Disorders at the University of Missouri Latha V. Soorya, PhD, BCBA Seaver Autism Center for Research and Treatment at the Icahn School of Medicine at Mount Sinai
• January 1st, 2012
• glutamate signaling system, molecular genetics, neuroinflammation, neuroscience, oxytocin, research
• 1040    0

There has been enormous growth over the past 10-15 years in research attempting to identify effective medications for children and youth with ASD. A few classes of medications have been shown to be effective for treating specific symptoms associated with autism. There is accumulating data to...

Social Skills Therapy Groups – Evaluating the Behavioral and Neural Impact for Children with Autism Spectrum Disorders

• By: Latha V. Soorya, PhD, BCBA Ting Wang, PhD Seaver Autism Center for Research and Treatment at the Icahn School of Medicine at Mount Sinai
• January 1st, 2009
• 1136    2

Social dysfunction is the central, unifying feature of autism spectrum disorders (ASD) and perhaps also the most debilitating. Impairments in socialization persist in individuals with ASD regardless of age or language level and are likely to impact quality of life variables, such as employment and...